glp 1 diabete Targeting GLP-1, GIP & GCG in Obesity and Type 2 Diabetes Research GLP-1 Receptor Agonists as Treatments

1- Visceral Fat Reduction (~1518%) Clinical studies have demonstrated that tesamorelin significantly reduces visceral adipose tissue (VAT) in individuals with HIV-associated lipodystrophy 2

doi: 10.1093/clinids/19.3.448 499 LoebelMEckeyMSotznyFHahnEBauerSGrabowskiPet al

[39] Studies looking for a correlation between prostatic hyperplasia and serum estrogen levels in humans have generally shown none

SalB can also ameliorate autophagy and upregulate Sirtuin1, which can both lessen renal pathological damage and improve renal insufficiency (Pan et al., 2011

used Cre-lox technology to delete the gene encoding the GLP-1R specifically in the CNS to reveal that GLP-1R agonist-induced weight loss requires GLP-1Rs in the CNS [13]